KRRO
Korro Bio, Inc.
10.60$
+0.9%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
Korro Bio, Inc. (KRRO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -17 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -30 | -9.4 | -10 | -11 | -15 | -25 | -18 | -15 | -18 | -17 | -13 | -12 | -11 | -20 | -15 | -12 | -40 | -22 | -15 | -16 | -7.5 | -24 | -19 | -17 | -18 | -16 | -17 | -68 | |
| 0.2 | 0.3 | 0.3 | 0.4 | 0.6 | 0.7 | 1.1 | 0.8 | 1.3 | 1.3 | 1.4 | 1.2 | 1.3 | 0.8 | 0.9 | 0.9 | 1.0 | 0.7 | 0.7 | 0.9 | 1.3 | 1.2 | 1.2 | 1.2 | 1.0 | 0.4 | 0.4 | 2.9 | |
| – | – | – | – | – | – | – | – | – | 0.0 | 0.3 | 0.3 | 0.2 | 0.3 | 0.4 | 0.4 | 1.2 | 0.9 | 1.0 | 1.3 | 1.4 | 1.8 | 2.0 | 1.8 | 2.1 | 2.7 | 2.7 | 9.3 | |
| -26 | -6.9 | -7.0 | -8.4 | -7.9 | -10 | -7.2 | 3.3 | -3.0 | -0.8 | 1.7 | 1.0 | -2.5 | -1.6 | 0.7 | 4.3 | 2.5 | -5.1 | 4.6 | 2.9 | 11 | -3.9 | 3.1 | -2.3 | -1.5 | 0.2 | -1.4 | -4.9 | |
| 0.4 | 0.3 | 0.9 | 1.0 | 4.4 | 0.5 | 2.0 | 0.3 | 0.1 | 0.0 | 0.0 | 0.0 | 5.2 | 1.5 | 4.4 | 0.2 | 7.7 | 5.6 | 6.0 | 4.9 | 1.5 | 0.1 | 0.1 | 0.2 | 0.1 | 0.0 | 0.0 | 0.3 | |
| 5.4 | 14 | 2.2 | -1.0 | -4.4 | -26 | -17 | -8.4 | -15 | -13 | 6.0 | 13 | 4.5 | 15 | -3.4 | 0.8 | -20 | -5.6 | -102 | -13 | -2.8 | 33 | -11 | 7.6 | 15 | -32 | -18 | -28 | |
| 82 | 0.3 | 0.4 | 41 | 15 | 0.6 | 0.3 | 0.3 | 0.1 | 0.2 | 0.0 | 0.1 | -0.2 | 45 | 0.0 | -2.2 | 202 | 0.1 | 68 | 0.7 | 0.9 | 0.2 | 0.0 | 0.1 | 0.4 | 88 | -2.9 | 86 | |
| 58 | 2.9 | -7.7 | 29 | -3.9 | -51 | -34 | -23 | -32 | -30 | -7.5 | 1.5 | -6.9 | 41 | -1.1 | 2.0 | 128 | -27 | -49 | -28 | -9.3 | 8.5 | -30 | -9.5 | -2.3 | 40 | -38 | -9.7 | |
| -30 | -9.7 | -11 | -12 | -19 | -26 | -20 | -15 | -18 | -17 | -13 | -12 | -16 | -21 | -19 | -12 | -48 | -28 | -21 | -21 | -8.9 | -25 | -19 | -17 | -18 | -16 | -17 | -68 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.